Brief: Aadi Bioscience Says Loretta Itri Notified Board That Her Employment As Chief Medical Officer Will Cease Effective Oct. 1, 2024

Whitehawk Therapeutics

22/08/2024 22:33

Aug 22 (Reuters) - Aadi Bioscience Inc  AADI.O :
    * AADI BIOSCIENCE - ON AUG 16, LORETTA ITRI, M.D. NOTIFIED
BOARD
THAT HER EMPLOYMENT AS CHIEF MEDICAL OFFICER WILL CEASE
EFFECTIVE OCTOBER 1, 2024
    * AADI BIOSCIENCE INC - BOARD HAS DETERMINED THAT ITRI'S
PENDING
CESSATION OF EMPLOYMENT IS A VOLUNTARY RESIGNATION
    * AADI BIOSCIENCE INC - ON AUGUST 20, NEIL DESAI, WAS
NOTIFIED
THAT HIS EMPLOYMENT AS EXECUTIVE CHAIRMAN OF COMPANY WILL CEASE
ON OCTOBER 1, 2024
    * AADI BIOSCIENCE INC - DESAI WILL CONTINUE TO SERVE AS A
MEMBER
OF BOARD

Source text for Eikon:  ID:n0001193125-24-205370 
Further company coverage:  AADI.O 

 ((Reuters.Briefs@thomsonreuters.com;))